The most significant interaction involves other glucose-lowering drugs
Multivariate analysis of 12-month HbA1c reported that HbA1c significantly increased after cessation of liraglutide in the liraglutide group by ~10.9 mmol/mol when compared to placebo (10.9 mmol/mol, 95%CI: 1.1, 20.6 mmol/mol, p = 0.032, Supplementary Table 5.4)
This semaglutide tablets vs injection guide gives general information about how medicines are usually taken, but your doctor knows you best
Nature 600 , 408418 (2021)
Patent Information: 2026 Novo Nordisk For more information go to www.OZEMPIC.com Marketed by: Novo Nordisk, Inc
This mechanism reduces appetite and promotes satiety but also delays how foodand oral medicationsmove through your stomach and small intestine